A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant
NCT ID: NCT01960361
Last Updated: 2019-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
35 participants
INTERVENTIONAL
2015-01-31
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of SPI Implant
NCT02367261
Alveolar Bone Loss Around 3 Different Designs of Dental Implant: Prospective Comparative Clinical Trail
NCT00544323
Long-term Study in Early Loaded Hydrophilic Surface Implants
NCT06138392
Comparison of Two Implant Prosthetic Pathways
NCT02905838
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
NCT06287346
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICE dental implant
Subjects implanted with ICE implant
ICE dental implant
ICE- Implant Classical Esthetic implant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICE dental implant
ICE- Implant Classical Esthetic implant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who are able to understand the requirements of the study, and are willing and able to comply with its instructions and schedules.
3. Patients who had provided written informed consent to participate in the study prior to any study procedure.
4. Patients in general good health in the opinion of the principal investigator as determined by medical history and oral examination.
Exclusion Criteria
2. Treatment with anticoagulant drugs (INR under 1.8) or bisphosphonates.
3. Treatment with anticonvulsants drugs.
4. Untreated Periodontal disease and inability of the patient to maintain reasonable oral hygiene according to study requirements.
5. Patients with history of alcohol, narcotics or drug abuse.
6. Patients under steroid therapy.
7. Patients receiving radiotherapy, chemotherapy or any other immunosuppressive treatment or who have been administered radiotherapy in the last 5 years.
Patients through at anytime received radiotherapy to the head and neck region will be excluded anyway.
8. Metabolic bone disorders and/or bone augmentation.
9. Uncontrolled bleeding disorders such as: hemophilia, thrombocytopenia, granulocytopenia.
10. Degenerative diseases.
11. Osteoradionecrosis.
12. Renal failure.
13. Organ transplant recipients.
14. HIV positive.
15. Malignant diseases.
16. Diseases that compromise the immune system.
17. Unbalanced diabetes mellitus. (HbA1c above 6.5)
18. Psychotic diseases.
19. Hypersensitivity to one of the components of the implant in general and titanium in particular.
20. Women who are pregnant or lactating.
21. Lack of patient cooperation.
22. Uncontrolled endocrine diseases.
23. Any systemic condition that is unbalanced and therefore precludes surgical procedures.
24. Parafunctional habits.- e.g Bruxism.
25. Temporomandibular joint disease.
26. Various pathologies of the oral mucosa for example: Benign mucous pemphigoid, desquamative ginigivitis, erosive lichen planus ,malignancy of oral cavity, bolus erosive diseases of the oral mucosa.
\-
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alpha - Bio Tec Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assaf Harofeh Medical Center
Rishon LeZiyyon, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICE_001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.